Managing haematological disorders during pregnancy.

Area of Science:

• Obstetrics and Hematology
• Reproductive Medicine
• Thrombosis and Hemostasis

Background:

• Pregnancy presents unique challenges for women with pre-existing hematological conditions.
• Malignant hematological disorders require careful management due to potential treatment toxicities.
• Pro-thrombotic states, such as antiphospholipid syndrome and essential thrombocythemia, are exacerbated by pregnancy's inherent pro-thrombotic nature.

Purpose of the Study:

• To highlight the critical need for multidisciplinary management of pregnant patients with hematological diseases.
• To emphasize the careful consideration of maternal and fetal risks associated with various hematological conditions during pregnancy.
• To underscore the importance of coordinated therapeutic strategies, including anticoagulation and anti-platelet therapy.

Main Methods:

• Review of clinical management strategies for pregnant patients with hematological disorders.
• Analysis of risks and outcomes in conditions like sickle cell disease, essential thrombocythemia, antiphospholipid syndrome, and thalassemias.
• Emphasis on collaborative care between obstetrics and hematology specialists.

Main Results:

• Joint management significantly improves outcomes for mothers and babies with hematological conditions.
• Careful timing and coordination of anticoagulation/anti-platelet therapy are crucial during antenatal, perinatal, and postnatal periods.
• Improved obstetric and hematological care, alongside multidisciplinary teamwork, has led to better outcomes in high-risk pregnancies like sickle cell disease.

Conclusions:

• Multidisciplinary teamwork is essential for managing pregnant patients with hematological diseases.
• Individualized management plans are necessary to mitigate maternal and fetal risks.
• Continued advancements in care have improved pregnancy outcomes for women with complex hematological conditions.